Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

A protective function for interleukin 17A in T cell-mediated intestinal inflammation.

O'Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, Kolls JK, Flavell RA.

Nat Immunol. 2009 Jun;10(6):603-9. doi: 10.1038/ni.1736.

2.

Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells.

Awasthi A, Riol-Blanco L, Jäger A, Korn T, Pot C, Galileos G, Bettelli E, Kuchroo VK, Oukka M.

J Immunol. 2009 May 15;182(10):5904-8. doi: 10.4049/jimmunol.0900732.

3.

The interleukin-23 axis in intestinal inflammation.

Ahern PP, Izcue A, Maloy KJ, Powrie F.

Immunol Rev. 2008 Dec;226:147-59. doi: 10.1111/j.1600-065X.2008.00705.x. Review.

PMID:
19161422
4.

TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.

Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE.

Mol Cell. 2008 Sep 26;31(6):918-24. doi: 10.1016/j.molcel.2008.09.002.

5.

The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.

Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landström M.

Nat Cell Biol. 2008 Oct;10(10):1199-207. doi: 10.1038/ncb1780. Epub 2008 Aug 31.

PMID:
18758450
7.

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat.

Manel N, Unutmaz D, Littman DR.

Nat Immunol. 2008 Jun;9(6):641-9. doi: 10.1038/ni.1610. Epub 2008 May 4.

8.

Regulation of inflammatory responses by IL-17F.

Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, Wang YH, Schluns KS, Broaddus RR, Zhu Z, Dong C.

J Exp Med. 2008 May 12;205(5):1063-75. doi: 10.1084/jem.20071978. Epub 2008 Apr 14.

9.

TH17 cells in development: an updated view of their molecular identity and genetic programming.

Dong C.

Nat Rev Immunol. 2008 May;8(5):337-48. doi: 10.1038/nri2295. Review.

PMID:
18408735
10.

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR.

Nature. 2008 May 8;453(7192):236-40. doi: 10.1038/nature06878. Epub 2008 Mar 26.

11.

Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation.

Chen Z, Laurence A, O'Shea JJ.

Semin Immunol. 2007 Dec;19(6):400-8. doi: 10.1016/j.smim.2007.10.015. Epub 2007 Dec 31. Review.

12.

Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer.

Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M.

Nat Immunol. 2008 Feb;9(2):194-202. Epub 2007 Dec 23.

PMID:
18157133
13.

Cutting edge: requirement for TRAF6 in the induction of T cell anergy.

King CG, Buckler JL, Kobayashi T, Hannah JR, Bassett G, Kim T, Pearce EL, Kim GG, Turka LA, Choi Y.

J Immunol. 2008 Jan 1;180(1):34-8.

14.

Characteristics and biological functions of TRAF6.

Inoue J, Gohda J, Akiyama T.

Adv Exp Med Biol. 2007;597:72-9. Review.

PMID:
17633018
15.

CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.

Kim HP, Leonard WJ.

J Exp Med. 2007 Jul 9;204(7):1543-51. Epub 2007 Jun 25.

16.

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.

Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, Strom TB, Oukka M, Kuchroo VK.

Nature. 2007 Jul 26;448(7152):484-7. Epub 2007 Jun 20.

17.

Chemically induced mouse models of intestinal inflammation.

Wirtz S, Neufert C, Weigmann B, Neurath MF.

Nat Protoc. 2007;2(3):541-6.

PMID:
17406617
18.

Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells.

Davidson TS, DiPaolo RJ, Andersson J, Shevach EM.

J Immunol. 2007 Apr 1;178(7):4022-6.

19.

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.

Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O'shea JJ.

Immunity. 2007 Mar;26(3):371-81.

20.

TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis.

King CG, Kobayashi T, Cejas PJ, Kim T, Yoon K, Kim GK, Chiffoleau E, Hickman SP, Walsh PT, Turka LA, Choi Y.

Nat Med. 2006 Sep;12(9):1088-92. Epub 2006 Jul 20.

PMID:
16921377

Supplemental Content

Support Center